NASDAQ
11.10.24
21:58 Uhr
10,090 US-Dollar
+0,110
+1,10 %
+1,10 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.09. | AdaptHealth clarifies warrant expiration date | 1 | Investing.com | ||
| 30.09. | AdaptHealth Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 25.09. | Adapthealth's former COO Shaw Rietkerk sells $281,000 worth of stock | 2 | Investing.com | ||
| 24.09. | AdaptHealth Target of Unusually High Options Trading (NASDAQ:AHCO) | 1 | MarketBeat | ||
| 23.09. | AdaptHealth-Aktien laut Baird bei aktuellen Bewertungskennzahlen attraktiv | - | Investing.com Deutsch | ||
| 17.09. | AdaptHealth Stock Earns RS Rating Upgrade | 1 | Investor's Business Daily | ||
| 16.09. | AdaptHealth sichert sich neue Kreditfazilität über 950 Millionen US-Dollar | 1 | Investing.com Deutsch | ||
| 16.09. | AdaptHealth Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.09. | Adapthealth CTO sells shares worth over $1.4 million | 2 | Investing.com | ||
| 04.09. | Adapthealth director Williams sells shares worth over $89k | 1 | Investing.com | ||
| 26.08. | AdaptHealth appoints Barnhart as COO | 2 | Seeking Alpha | ||
| 26.08. | AdaptHealth names new COO to enhance operations | 1 | Investing.com | ||
| 19.08. | AdaptHealth announces executive role shift for COO | 1 | Investing.com | ||
| 19.08. | AdaptHealth Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.08. | UBS maintains buy on AdaptHealth with steady price target | 5 | Investing.com | ||
| 07.08. | Earnings call: AdaptHealth reports growth and strategic sales in Q2 2024 | 1 | Investing.com | ||
| 06.08. | AdaptHealth Corp. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 06.08. | AdaptHealth falls after narrowing 2024 revenue forecast | 1 | Reuters | ||
| 06.08. | Adapthealth Corp reports results for the quarter ended in June - Earnings Summary | 1 | Reuters | ||
| 06.08. | AdaptHealth GAAP EPS of $0.13 misses by $0.02, revenue of $805.98M beats by $3.36M | 1 | Seeking Alpha |
Seite:
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 41,940 | +2,95 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler und GlyTherix unterzeichnen Vertrag zur Lieferung von Lutetium-177 | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Vertrag/Kooperation
Eckert & Ziegler und GlyTherix unterzeichnen Vertrag zur Lieferung von Lutetium-177
08.10.2024 / 08:00... ► Artikel lesen | |
| INTUITIVE SURGICAL | 442,80 | -0,10 % | Intuitive Surgical Aktie: Leichter Kursanstieg trotz Monatsverlust | Die Intuitive Surgical Aktie verzeichnete am 12. Oktober 2024 einen leichten Anstieg von 0,19% auf 484,78 USD. Trotz dieses moderaten Zuwachses steht die Aktie des führenden Anbieters von Robotersystemen... ► Artikel lesen | |
| SYNLAB | 10,920 | 0,00 % | Cinven To Sell Minority Stake In Synlab To LabCorp. | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - International private equity firm, Cinven, Monday announced an agreement to sell an indirect minority stake in SYNLAB to strategic investor LabCorp, an innovative... ► Artikel lesen | |
| HIMS & HERS HEALTH | 17,075 | -0,15 % | S&P Dow Jones Indices: Hims & Hers Health Set to Join S&P SmallCap 600 | NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday... ► Artikel lesen | |
| HEALWELL AI | 0,910 | -0,44 % | Haywood launches coverage of HEALWELL AI with a "Buy" rating | ||
| CO-DIAGNOSTICS | 1,140 | -6,56 % | Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results | SALT LAKE CITY, August 8, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic... ► Artikel lesen | |
| EMEIS | 5,479 | -0,67 % | emeis: Availability of the 2024 Half-Year Financial Report | Regulatory News:
emeis (Paris:EMEIS) filed, today, its half-year financial report for the period starting on 1 January 2024 and ending on 30 June 2024, with the French Autorité des Marchés Financiers... ► Artikel lesen | |
| LIFEWARD | 2,870 | -4,33 % | Lifeward, Inc.: Lifeward Launches Direct Sales of AlterG Product Line in Germany | MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global market leader delivering life-changing... ► Artikel lesen | |
| VERU | 0,817 | +3,42 % | Veru Inc.: Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results | --Phase 2b QUALITY study of enobosarm in combination with semaglutide (Wegovy®*) exceeds targeted full enrollment of >150 patients-- --Topline data for primary endpoint of lean body mass expected... ► Artikel lesen | |
| LIMES SCHLOSSKLINIKEN | 356,00 | 0,00 % | EQS-Adhoc: Limes Schlosskliniken AG: Positiver Geschäftsverlauf I. Halbjahr 2024 | EQS-Ad-hoc: Limes Schlosskliniken AG / Schlagwort(e): Halbjahresbericht/Vorläufiges Ergebnis
Limes Schlosskliniken AG: Positiver Geschäftsverlauf I. Halbjahr 2024
18.07.2024 / 10:17 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| PATTERSON COMPANIES | 18,300 | -3,17 % | 6 Analysts Have This To Say About Patterson Cos | ||
| CLOVER HEALTH INVESTMENTS | 3,811 | +2,50 % | Clover Health Investments, Corp.: Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer | FRANKLIN, Tenn., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ("Counterpart"), a leading AI-powered physician enablement platform, today announced the appointment of David Tsay M.D.... ► Artikel lesen | |
| NANO-X IMAGING | 6,015 | +1,26 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
| LANTHEUS | 101,45 | -1,17 % | Lantheus Holdings, Inc.: Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024 | Study met its primary endpoint, demonstrating significant improvement in radiographic progression-free survival Overall Response Rate was 38.1% vs. 12.0% for the ARPI switch arm, including 9.3% Complete... ► Artikel lesen | |
| TEMPUS AI | 48,790 | +6,11 % | Tempus AI, Inc.: Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024 | Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced four abstracts were accepted for presentation at the... ► Artikel lesen |
ADAPTHEALTH CORP gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +1,10 % bei einem Aktienkurs von 10,090 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADAPTHEALTH CORP finden Sie auf Wallstreet Online.
